nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—AOX1—Brimonidine—glaucoma	0.553	0.824	CbGbCtD
Raloxifene—CYP3A4—Pilocarpine—glaucoma	0.0277	0.0414	CbGbCtD
Raloxifene—CYP3A4—Brinzolamide—glaucoma	0.0218	0.0324	CbGbCtD
Raloxifene—CYP3A4—Dorzolamide—glaucoma	0.021	0.0313	CbGbCtD
Raloxifene—CYP3A4—Methazolamide—glaucoma	0.0187	0.0279	CbGbCtD
Raloxifene—CYP3A4—Acetazolamide—glaucoma	0.015	0.0223	CbGbCtD
Raloxifene—CYP3A4—Clonidine—glaucoma	0.0135	0.0202	CbGbCtD
Raloxifene—EBP—Treprostinil—Latanoprost—glaucoma	0.0033	1	CbGdCrCtD
Raloxifene—Rhinitis—Clonidine—glaucoma	0.000436	0.00166	CcSEcCtD
Raloxifene—Cough—Travoprost—glaucoma	0.000435	0.00166	CcSEcCtD
Raloxifene—Vomiting—Carbachol—glaucoma	0.000435	0.00165	CcSEcCtD
Raloxifene—Hypoaesthesia—Clonidine—glaucoma	0.000432	0.00165	CcSEcCtD
Raloxifene—Rash—Carbachol—glaucoma	0.000431	0.00164	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000431	0.00164	CcSEcCtD
Raloxifene—Dermatitis—Carbachol—glaucoma	0.00043	0.00164	CcSEcCtD
Raloxifene—Weight increased—Betaxolol—glaucoma	0.00043	0.00164	CcSEcCtD
Raloxifene—Cough—Brinzolamide—glaucoma	0.00043	0.00164	CcSEcCtD
Raloxifene—Headache—Carbachol—glaucoma	0.000428	0.00163	CcSEcCtD
Raloxifene—Chest pain—Dorzolamide—glaucoma	0.000427	0.00162	CcSEcCtD
Raloxifene—Arthralgia—Dorzolamide—glaucoma	0.000427	0.00162	CcSEcCtD
Raloxifene—Pain—Apraclonidine—glaucoma	0.000427	0.00162	CcSEcCtD
Raloxifene—Dyspepsia—Bimatoprost—glaucoma	0.000426	0.00162	CcSEcCtD
Raloxifene—Infection—Brimonidine—glaucoma	0.000426	0.00162	CcSEcCtD
Raloxifene—Myalgia—Travoprost—glaucoma	0.000425	0.00162	CcSEcCtD
Raloxifene—Chest pain—Travoprost—glaucoma	0.000425	0.00162	CcSEcCtD
Raloxifene—Arthralgia—Travoprost—glaucoma	0.000425	0.00162	CcSEcCtD
Raloxifene—Syncope—Pilocarpine—glaucoma	0.000425	0.00162	CcSEcCtD
Raloxifene—Pneumonia—Betaxolol—glaucoma	0.000424	0.00161	CcSEcCtD
Raloxifene—Nausea—Carteolol—glaucoma	0.000423	0.00161	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000422	0.00161	CcSEcCtD
Raloxifene—Headache—Levobunolol—glaucoma	0.000422	0.0016	CcSEcCtD
Raloxifene—Shock—Brimonidine—glaucoma	0.000421	0.0016	CcSEcCtD
Raloxifene—Depression—Betaxolol—glaucoma	0.00042	0.0016	CcSEcCtD
Raloxifene—Nervous system disorder—Brimonidine—glaucoma	0.00042	0.0016	CcSEcCtD
Raloxifene—Chest pain—Brinzolamide—glaucoma	0.000419	0.0016	CcSEcCtD
Raloxifene—Myalgia—Brinzolamide—glaucoma	0.000419	0.0016	CcSEcCtD
Raloxifene—Arthralgia—Brinzolamide—glaucoma	0.000419	0.0016	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000418	0.00159	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000417	0.00159	CcSEcCtD
Raloxifene—Loss of consciousness—Pilocarpine—glaucoma	0.000416	0.00158	CcSEcCtD
Raloxifene—Skin disorder—Brimonidine—glaucoma	0.000416	0.00158	CcSEcCtD
Raloxifene—Nausea—Diclofenamide—glaucoma	0.000416	0.00158	CcSEcCtD
Raloxifene—Pain—Bimatoprost—glaucoma	0.000414	0.00157	CcSEcCtD
Raloxifene—Cough—Pilocarpine—glaucoma	0.000413	0.00157	CcSEcCtD
Raloxifene—Dizziness—Latanoprost—glaucoma	0.000413	0.00157	CcSEcCtD
Raloxifene—Vomiting—Methazolamide—glaucoma	0.00041	0.00156	CcSEcCtD
Raloxifene—Conjunctivitis—Betaxolol—glaucoma	0.00041	0.00156	CcSEcCtD
Raloxifene—Gastrointestinal pain—Apraclonidine—glaucoma	0.000408	0.00155	CcSEcCtD
Raloxifene—Rash—Methazolamide—glaucoma	0.000406	0.00155	CcSEcCtD
Raloxifene—Dermatitis—Methazolamide—glaucoma	0.000406	0.00155	CcSEcCtD
Raloxifene—Nausea—Carbachol—glaucoma	0.000406	0.00154	CcSEcCtD
Raloxifene—Infection—Travoprost—glaucoma	0.000405	0.00154	CcSEcCtD
Raloxifene—Sweating—Betaxolol—glaucoma	0.000404	0.00154	CcSEcCtD
Raloxifene—Headache—Methazolamide—glaucoma	0.000404	0.00154	CcSEcCtD
Raloxifene—Breast disorder—Timolol—glaucoma	0.000404	0.00154	CcSEcCtD
Raloxifene—Cardiac disorder—Clonidine—glaucoma	0.000403	0.00153	CcSEcCtD
Raloxifene—Myalgia—Pilocarpine—glaucoma	0.000403	0.00153	CcSEcCtD
Raloxifene—Arthralgia—Pilocarpine—glaucoma	0.000403	0.00153	CcSEcCtD
Raloxifene—Chest pain—Pilocarpine—glaucoma	0.000403	0.00153	CcSEcCtD
Raloxifene—Shock—Dorzolamide—glaucoma	0.000402	0.00153	CcSEcCtD
Raloxifene—Nausea—Levobunolol—glaucoma	0.0004	0.00152	CcSEcCtD
Raloxifene—Infection—Brinzolamide—glaucoma	0.0004	0.00152	CcSEcCtD
Raloxifene—Nervous system disorder—Travoprost—glaucoma	0.000399	0.00152	CcSEcCtD
Raloxifene—Skin disorder—Travoprost—glaucoma	0.000396	0.00151	CcSEcCtD
Raloxifene—Hyperhidrosis—Dorzolamide—glaucoma	0.000395	0.0015	CcSEcCtD
Raloxifene—Sinusitis—Betaxolol—glaucoma	0.000395	0.0015	CcSEcCtD
Raloxifene—Abdominal pain—Apraclonidine—glaucoma	0.000394	0.0015	CcSEcCtD
Raloxifene—Nervous system disorder—Brinzolamide—glaucoma	0.000394	0.0015	CcSEcCtD
Raloxifene—Angiopathy—Clonidine—glaucoma	0.000394	0.0015	CcSEcCtD
Raloxifene—Rash—Latanoprost—glaucoma	0.000393	0.0015	CcSEcCtD
Raloxifene—Dermatitis—Latanoprost—glaucoma	0.000393	0.0015	CcSEcCtD
Raloxifene—Dyspepsia—Acetazolamide—glaucoma	0.000393	0.0015	CcSEcCtD
Raloxifene—Headache—Latanoprost—glaucoma	0.000391	0.00149	CcSEcCtD
Raloxifene—Skin disorder—Brinzolamide—glaucoma	0.000391	0.00149	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00039	0.00149	CcSEcCtD
Raloxifene—Insomnia—Brimonidine—glaucoma	0.000387	0.00147	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000385	0.00147	CcSEcCtD
Raloxifene—Infection—Pilocarpine—glaucoma	0.000384	0.00146	CcSEcCtD
Raloxifene—Nausea—Methazolamide—glaucoma	0.000383	0.00146	CcSEcCtD
Raloxifene—Shock—Pilocarpine—glaucoma	0.00038	0.00145	CcSEcCtD
Raloxifene—Rhinitis—Betaxolol—glaucoma	0.000379	0.00144	CcSEcCtD
Raloxifene—Thrombocytopenia—Pilocarpine—glaucoma	0.000378	0.00144	CcSEcCtD
Raloxifene—Dyspepsia—Brimonidine—glaucoma	0.000377	0.00143	CcSEcCtD
Raloxifene—Hypoaesthesia—Betaxolol—glaucoma	0.000376	0.00143	CcSEcCtD
Raloxifene—Pharyngitis—Betaxolol—glaucoma	0.000375	0.00143	CcSEcCtD
Raloxifene—Hyperhidrosis—Pilocarpine—glaucoma	0.000374	0.00142	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000373	0.00142	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Travoprost—glaucoma	0.000371	0.00141	CcSEcCtD
Raloxifene—Insomnia—Dorzolamide—glaucoma	0.00037	0.00141	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Brimonidine—glaucoma	0.00037	0.00141	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000366	0.00139	CcSEcCtD
Raloxifene—Pain—Brimonidine—glaucoma	0.000366	0.00139	CcSEcCtD
Raloxifene—Insomnia—Brinzolamide—glaucoma	0.000364	0.00138	CcSEcCtD
Raloxifene—Muscle spasms—Clonidine—glaucoma	0.000364	0.00138	CcSEcCtD
Raloxifene—Dyspepsia—Dorzolamide—glaucoma	0.00036	0.00137	CcSEcCtD
Raloxifene—Dyspepsia—Travoprost—glaucoma	0.000359	0.00136	CcSEcCtD
Raloxifene—Dyspepsia—Brinzolamide—glaucoma	0.000354	0.00135	CcSEcCtD
Raloxifene—Body temperature increased—Acetazolamide—glaucoma	0.000353	0.00134	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000352	0.00134	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Travoprost—glaucoma	0.000352	0.00134	CcSEcCtD
Raloxifene—Flushing—Betaxolol—glaucoma	0.000351	0.00134	CcSEcCtD
Raloxifene—Cardiac disorder—Betaxolol—glaucoma	0.000351	0.00134	CcSEcCtD
Raloxifene—Pain—Dorzolamide—glaucoma	0.00035	0.00133	CcSEcCtD
Raloxifene—Insomnia—Pilocarpine—glaucoma	0.00035	0.00133	CcSEcCtD
Raloxifene—Pain—Travoprost—glaucoma	0.000348	0.00133	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000347	0.00132	CcSEcCtD
Raloxifene—Pain—Brinzolamide—glaucoma	0.000344	0.00131	CcSEcCtD
Raloxifene—Depression—Timolol—glaucoma	0.000343	0.00131	CcSEcCtD
Raloxifene—Angiopathy—Betaxolol—glaucoma	0.000343	0.00131	CcSEcCtD
Raloxifene—Diarrhoea—Apraclonidine—glaucoma	0.000341	0.0013	CcSEcCtD
Raloxifene—Dyspepsia—Pilocarpine—glaucoma	0.00034	0.00129	CcSEcCtD
Raloxifene—Syncope—Clonidine—glaucoma	0.000339	0.00129	CcSEcCtD
Raloxifene—Conjunctivitis—Timolol—glaucoma	0.000335	0.00127	CcSEcCtD
Raloxifene—Gastrointestinal pain—Dorzolamide—glaucoma	0.000334	0.00127	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000334	0.00127	CcSEcCtD
Raloxifene—Gastrointestinal pain—Travoprost—glaucoma	0.000333	0.00127	CcSEcCtD
Raloxifene—Loss of consciousness—Clonidine—glaucoma	0.000332	0.00127	CcSEcCtD
Raloxifene—Pain—Pilocarpine—glaucoma	0.000331	0.00126	CcSEcCtD
Raloxifene—Cough—Clonidine—glaucoma	0.00033	0.00126	CcSEcCtD
Raloxifene—Sweating—Timolol—glaucoma	0.00033	0.00126	CcSEcCtD
Raloxifene—Dizziness—Apraclonidine—glaucoma	0.00033	0.00126	CcSEcCtD
Raloxifene—Body temperature increased—Dorzolamide—glaucoma	0.000323	0.00123	CcSEcCtD
Raloxifene—Abdominal pain—Dorzolamide—glaucoma	0.000323	0.00123	CcSEcCtD
Raloxifene—Sinusitis—Timolol—glaucoma	0.000323	0.00123	CcSEcCtD
Raloxifene—Chest pain—Clonidine—glaucoma	0.000322	0.00123	CcSEcCtD
Raloxifene—Arthralgia—Clonidine—glaucoma	0.000322	0.00123	CcSEcCtD
Raloxifene—Abdominal pain—Travoprost—glaucoma	0.000322	0.00123	CcSEcCtD
Raloxifene—Dizziness—Bimatoprost—glaucoma	0.00032	0.00122	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00032	0.00122	CcSEcCtD
Raloxifene—Vomiting—Apraclonidine—glaucoma	0.000317	0.00121	CcSEcCtD
Raloxifene—Muscle spasms—Betaxolol—glaucoma	0.000317	0.0012	CcSEcCtD
Raloxifene—Gastrointestinal pain—Pilocarpine—glaucoma	0.000316	0.0012	CcSEcCtD
Raloxifene—Dermatitis—Apraclonidine—glaucoma	0.000314	0.0012	CcSEcCtD
Raloxifene—Headache—Apraclonidine—glaucoma	0.000313	0.00119	CcSEcCtD
Raloxifene—Rhinitis—Timolol—glaucoma	0.00031	0.00118	CcSEcCtD
Raloxifene—Infection—Clonidine—glaucoma	0.000307	0.00117	CcSEcCtD
Raloxifene—Abdominal pain—Pilocarpine—glaucoma	0.000306	0.00116	CcSEcCtD
Raloxifene—Body temperature increased—Pilocarpine—glaucoma	0.000306	0.00116	CcSEcCtD
Raloxifene—Diarrhoea—Acetazolamide—glaucoma	0.000305	0.00116	CcSEcCtD
Raloxifene—Rash—Bimatoprost—glaucoma	0.000305	0.00116	CcSEcCtD
Raloxifene—Dermatitis—Bimatoprost—glaucoma	0.000305	0.00116	CcSEcCtD
Raloxifene—Oedema peripheral—Timolol—glaucoma	0.000304	0.00116	CcSEcCtD
Raloxifene—Shock—Clonidine—glaucoma	0.000304	0.00116	CcSEcCtD
Raloxifene—Connective tissue disorder—Timolol—glaucoma	0.000304	0.00116	CcSEcCtD
Raloxifene—Headache—Bimatoprost—glaucoma	0.000303	0.00115	CcSEcCtD
Raloxifene—Nervous system disorder—Clonidine—glaucoma	0.000303	0.00115	CcSEcCtD
Raloxifene—Thrombocytopenia—Clonidine—glaucoma	0.000302	0.00115	CcSEcCtD
Raloxifene—Skin disorder—Clonidine—glaucoma	0.0003	0.00114	CcSEcCtD
Raloxifene—Hyperhidrosis—Clonidine—glaucoma	0.000298	0.00114	CcSEcCtD
Raloxifene—Nausea—Apraclonidine—glaucoma	0.000296	0.00113	CcSEcCtD
Raloxifene—Vertigo—Betaxolol—glaucoma	0.000296	0.00113	CcSEcCtD
Raloxifene—Syncope—Betaxolol—glaucoma	0.000295	0.00112	CcSEcCtD
Raloxifene—Dizziness—Acetazolamide—glaucoma	0.000295	0.00112	CcSEcCtD
Raloxifene—Loss of consciousness—Betaxolol—glaucoma	0.000289	0.0011	CcSEcCtD
Raloxifene—Cough—Betaxolol—glaucoma	0.000287	0.00109	CcSEcCtD
Raloxifene—Nausea—Bimatoprost—glaucoma	0.000287	0.00109	CcSEcCtD
Raloxifene—Cardiac disorder—Timolol—glaucoma	0.000287	0.00109	CcSEcCtD
Raloxifene—Vomiting—Acetazolamide—glaucoma	0.000284	0.00108	CcSEcCtD
Raloxifene—Dizziness—Brimonidine—glaucoma	0.000283	0.00108	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Clonidine—glaucoma	0.000281	0.00107	CcSEcCtD
Raloxifene—Angiopathy—Timolol—glaucoma	0.00028	0.00107	CcSEcCtD
Raloxifene—Arthralgia—Betaxolol—glaucoma	0.00028	0.00107	CcSEcCtD
Raloxifene—Chest pain—Betaxolol—glaucoma	0.00028	0.00107	CcSEcCtD
Raloxifene—Myalgia—Betaxolol—glaucoma	0.00028	0.00107	CcSEcCtD
Raloxifene—Diarrhoea—Dorzolamide—glaucoma	0.00028	0.00107	CcSEcCtD
Raloxifene—Headache—Acetazolamide—glaucoma	0.00028	0.00106	CcSEcCtD
Raloxifene—Insomnia—Clonidine—glaucoma	0.000279	0.00106	CcSEcCtD
Raloxifene—Diarrhoea—Travoprost—glaucoma	0.000279	0.00106	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000278	0.00106	CcSEcCtD
Raloxifene—Diarrhoea—Brinzolamide—glaucoma	0.000275	0.00105	CcSEcCtD
Raloxifene—Dizziness—Dorzolamide—glaucoma	0.00027	0.00103	CcSEcCtD
Raloxifene—Rash—Brimonidine—glaucoma	0.00027	0.00103	CcSEcCtD
Raloxifene—Dermatitis—Brimonidine—glaucoma	0.00027	0.00103	CcSEcCtD
Raloxifene—Dizziness—Travoprost—glaucoma	0.000269	0.00103	CcSEcCtD
Raloxifene—Headache—Brimonidine—glaucoma	0.000268	0.00102	CcSEcCtD
Raloxifene—Infection—Betaxolol—glaucoma	0.000267	0.00102	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Clonidine—glaucoma	0.000266	0.00101	CcSEcCtD
Raloxifene—Dizziness—Brinzolamide—glaucoma	0.000266	0.00101	CcSEcCtD
Raloxifene—Nausea—Acetazolamide—glaucoma	0.000265	0.00101	CcSEcCtD
Raloxifene—Diarrhoea—Pilocarpine—glaucoma	0.000264	0.00101	CcSEcCtD
Raloxifene—Shock—Betaxolol—glaucoma	0.000264	0.00101	CcSEcCtD
Raloxifene—Pain—Clonidine—glaucoma	0.000264	0.001	CcSEcCtD
Raloxifene—Nervous system disorder—Betaxolol—glaucoma	0.000264	0.001	CcSEcCtD
Raloxifene—Thrombocytopenia—Betaxolol—glaucoma	0.000263	0.001	CcSEcCtD
Raloxifene—Skin disorder—Betaxolol—glaucoma	0.000261	0.000993	CcSEcCtD
Raloxifene—Vomiting—Dorzolamide—glaucoma	0.00026	0.00099	CcSEcCtD
Raloxifene—Hyperhidrosis—Betaxolol—glaucoma	0.00026	0.000989	CcSEcCtD
Raloxifene—Rash—Dorzolamide—glaucoma	0.000258	0.000982	CcSEcCtD
Raloxifene—Dermatitis—Dorzolamide—glaucoma	0.000258	0.000981	CcSEcCtD
Raloxifene—Rash—Travoprost—glaucoma	0.000257	0.000977	CcSEcCtD
Raloxifene—Dermatitis—Travoprost—glaucoma	0.000257	0.000976	CcSEcCtD
Raloxifene—Headache—Dorzolamide—glaucoma	0.000256	0.000975	CcSEcCtD
Raloxifene—Vomiting—Brinzolamide—glaucoma	0.000256	0.000973	CcSEcCtD
Raloxifene—Dizziness—Pilocarpine—glaucoma	0.000256	0.000973	CcSEcCtD
Raloxifene—Headache—Travoprost—glaucoma	0.000255	0.000971	CcSEcCtD
Raloxifene—Nausea—Brimonidine—glaucoma	0.000254	0.000968	CcSEcCtD
Raloxifene—Rash—Brinzolamide—glaucoma	0.000254	0.000965	CcSEcCtD
Raloxifene—Dermatitis—Brinzolamide—glaucoma	0.000253	0.000964	CcSEcCtD
Raloxifene—Gastrointestinal pain—Clonidine—glaucoma	0.000252	0.000961	CcSEcCtD
Raloxifene—Headache—Brinzolamide—glaucoma	0.000252	0.000959	CcSEcCtD
Raloxifene—Vomiting—Pilocarpine—glaucoma	0.000246	0.000935	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000245	0.000932	CcSEcCtD
Raloxifene—Abdominal pain—Clonidine—glaucoma	0.000244	0.000929	CcSEcCtD
Raloxifene—Body temperature increased—Clonidine—glaucoma	0.000244	0.000929	CcSEcCtD
Raloxifene—Rash—Pilocarpine—glaucoma	0.000244	0.000927	CcSEcCtD
Raloxifene—Dermatitis—Pilocarpine—glaucoma	0.000243	0.000927	CcSEcCtD
Raloxifene—Insomnia—Betaxolol—glaucoma	0.000243	0.000925	CcSEcCtD
Raloxifene—Nausea—Dorzolamide—glaucoma	0.000243	0.000925	CcSEcCtD
Raloxifene—Headache—Pilocarpine—glaucoma	0.000242	0.000922	CcSEcCtD
Raloxifene—Nausea—Travoprost—glaucoma	0.000242	0.000921	CcSEcCtD
Raloxifene—Vertigo—Timolol—glaucoma	0.000242	0.00092	CcSEcCtD
Raloxifene—Syncope—Timolol—glaucoma	0.000241	0.000918	CcSEcCtD
Raloxifene—Nausea—Brinzolamide—glaucoma	0.000239	0.000909	CcSEcCtD
Raloxifene—Dyspepsia—Betaxolol—glaucoma	0.000237	0.0009	CcSEcCtD
Raloxifene—Loss of consciousness—Timolol—glaucoma	0.000236	0.0009	CcSEcCtD
Raloxifene—Cough—Timolol—glaucoma	0.000235	0.000893	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Betaxolol—glaucoma	0.000232	0.000883	CcSEcCtD
Raloxifene—Pain—Betaxolol—glaucoma	0.00023	0.000875	CcSEcCtD
Raloxifene—Nausea—Pilocarpine—glaucoma	0.00023	0.000874	CcSEcCtD
Raloxifene—Arthralgia—Timolol—glaucoma	0.000229	0.000872	CcSEcCtD
Raloxifene—Chest pain—Timolol—glaucoma	0.000229	0.000872	CcSEcCtD
Raloxifene—Myalgia—Timolol—glaucoma	0.000229	0.000872	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000227	0.000866	CcSEcCtD
Raloxifene—Infection—Timolol—glaucoma	0.000218	0.00083	CcSEcCtD
Raloxifene—Shock—Timolol—glaucoma	0.000216	0.000822	CcSEcCtD
Raloxifene—Nervous system disorder—Timolol—glaucoma	0.000215	0.000819	CcSEcCtD
Raloxifene—Skin disorder—Timolol—glaucoma	0.000213	0.000812	CcSEcCtD
Raloxifene—Body temperature increased—Betaxolol—glaucoma	0.000212	0.000808	CcSEcCtD
Raloxifene—Hyperhidrosis—Timolol—glaucoma	0.000212	0.000808	CcSEcCtD
Raloxifene—Diarrhoea—Clonidine—glaucoma	0.000211	0.000804	CcSEcCtD
Raloxifene—Dizziness—Clonidine—glaucoma	0.000204	0.000777	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Timolol—glaucoma	0.0002	0.000761	CcSEcCtD
Raloxifene—Insomnia—Timolol—glaucoma	0.000199	0.000756	CcSEcCtD
Raloxifene—Vomiting—Clonidine—glaucoma	0.000196	0.000747	CcSEcCtD
Raloxifene—Rash—Clonidine—glaucoma	0.000195	0.000741	CcSEcCtD
Raloxifene—Dermatitis—Clonidine—glaucoma	0.000194	0.00074	CcSEcCtD
Raloxifene—Headache—Clonidine—glaucoma	0.000193	0.000736	CcSEcCtD
Raloxifene—Dyspepsia—Timolol—glaucoma	0.000193	0.000735	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Timolol—glaucoma	0.00019	0.000721	CcSEcCtD
Raloxifene—Pain—Timolol—glaucoma	0.000188	0.000714	CcSEcCtD
Raloxifene—Diarrhoea—Betaxolol—glaucoma	0.000184	0.0007	CcSEcCtD
Raloxifene—Nausea—Clonidine—glaucoma	0.000183	0.000698	CcSEcCtD
Raloxifene—Gastrointestinal pain—Timolol—glaucoma	0.00018	0.000683	CcSEcCtD
Raloxifene—Dizziness—Betaxolol—glaucoma	0.000178	0.000676	CcSEcCtD
Raloxifene—Body temperature increased—Timolol—glaucoma	0.000174	0.00066	CcSEcCtD
Raloxifene—Abdominal pain—Timolol—glaucoma	0.000174	0.00066	CcSEcCtD
Raloxifene—Vomiting—Betaxolol—glaucoma	0.000171	0.00065	CcSEcCtD
Raloxifene—Rash—Betaxolol—glaucoma	0.000169	0.000645	CcSEcCtD
Raloxifene—Dermatitis—Betaxolol—glaucoma	0.000169	0.000644	CcSEcCtD
Raloxifene—Headache—Betaxolol—glaucoma	0.000168	0.000641	CcSEcCtD
Raloxifene—Nausea—Betaxolol—glaucoma	0.00016	0.000607	CcSEcCtD
Raloxifene—Diarrhoea—Timolol—glaucoma	0.00015	0.000572	CcSEcCtD
Raloxifene—Dizziness—Timolol—glaucoma	0.000145	0.000552	CcSEcCtD
Raloxifene—Vomiting—Timolol—glaucoma	0.00014	0.000531	CcSEcCtD
Raloxifene—Rash—Timolol—glaucoma	0.000138	0.000527	CcSEcCtD
Raloxifene—Dermatitis—Timolol—glaucoma	0.000138	0.000526	CcSEcCtD
Raloxifene—Headache—Timolol—glaucoma	0.000138	0.000523	CcSEcCtD
Raloxifene—Nausea—Timolol—glaucoma	0.00013	0.000496	CcSEcCtD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000111	0.00176	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GSTT1—glaucoma	0.00011	0.00175	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000109	0.00172	CbGpPWpGaD
Raloxifene—ESR1—LKB1 signaling events—TP53—glaucoma	0.000107	0.0017	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000107	0.0017	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000107	0.0017	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—OPN4—glaucoma	0.000104	0.00164	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PTGFR—glaucoma	0.000103	0.00163	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000103	0.00163	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000102	0.00162	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PTGFR—glaucoma	0.000102	0.00162	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000102	0.00161	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—CDKN2B—glaucoma	0.000101	0.0016	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GSTT1—glaucoma	0.000101	0.0016	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000101	0.00159	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—SMO—glaucoma	0.0001	0.00159	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.0001	0.00159	CbGpPWpGaD
Raloxifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.0001	0.00158	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	9.96e-05	0.00158	CbGpPWpGaD
Raloxifene—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.86e-05	0.00156	CbGpPWpGaD
Raloxifene—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	9.71e-05	0.00154	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LRP12—glaucoma	9.68e-05	0.00153	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—CYP1B1—glaucoma	9.47e-05	0.0015	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	9.34e-05	0.00148	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PTGFR—glaucoma	9.33e-05	0.00148	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—SMO—glaucoma	9.17e-05	0.00145	CbGpPWpGaD
Raloxifene—AOX1—Disease—HDAC9—glaucoma	9.13e-05	0.00145	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	8.98e-05	0.00142	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—BAD—glaucoma	8.93e-05	0.00142	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.91e-05	0.00141	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—NR3C1—glaucoma	8.85e-05	0.0014	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LRP12—glaucoma	8.84e-05	0.0014	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CYP1B1—glaucoma	8.8e-05	0.0014	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ABCA1—glaucoma	8.8e-05	0.0014	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	8.7e-05	0.00138	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	8.7e-05	0.00138	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TNF—glaucoma	8.61e-05	0.00137	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	8.55e-05	0.00136	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CA5A—glaucoma	8.33e-05	0.00132	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NARFL—glaucoma	8.33e-05	0.00132	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.1e-05	0.00128	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—CYP1B1—glaucoma	8.02e-05	0.00127	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	7.94e-05	0.00126	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	7.91e-05	0.00125	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—TXN—glaucoma	7.9e-05	0.00125	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	7.6e-05	0.0012	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GSTM1—glaucoma	7.57e-05	0.0012	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.49e-05	0.00119	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	7.47e-05	0.00118	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	7.44e-05	0.00118	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LRP12—glaucoma	7.36e-05	0.00117	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7.33e-05	0.00116	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—glaucoma	7.27e-05	0.00115	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CA5A—glaucoma	7.05e-05	0.00112	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NARFL—glaucoma	7.05e-05	0.00112	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GSTM1—glaucoma	7.04e-05	0.00112	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.94e-05	0.0011	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—OPN4—glaucoma	6.71e-05	0.00106	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—EDN1—glaucoma	6.62e-05	0.00105	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.46e-05	0.00102	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GSTM1—glaucoma	6.41e-05	0.00102	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CA1—glaucoma	6.34e-05	0.001	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	6.32e-05	0.001	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HEYL—glaucoma	6.24e-05	0.000989	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	6.22e-05	0.000987	CbGpPWpGaD
Raloxifene—EBP—Metabolism—MTHFR—glaucoma	6.22e-05	0.000986	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CTSA—glaucoma	6.14e-05	0.000973	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—OPN4—glaucoma	6.12e-05	0.000971	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTT1—glaucoma	6.12e-05	0.000971	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—EDN1—glaucoma	6.05e-05	0.000959	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTGFR—glaucoma	6.04e-05	0.000958	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	5.81e-05	0.000921	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CA2—glaucoma	5.79e-05	0.000919	CbGpPWpGaD
Raloxifene—EBP—Metabolism—APOE—glaucoma	5.79e-05	0.000918	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—C3—glaucoma	5.79e-05	0.000918	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CAV1—glaucoma	5.74e-05	0.000909	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HEYL—glaucoma	5.69e-05	0.000903	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.66e-05	0.000898	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.66e-05	0.000898	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTGFR—glaucoma	5.51e-05	0.000874	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	5.47e-05	0.000868	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.4e-05	0.000856	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—C3—glaucoma	5.28e-05	0.000838	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	5.2e-05	0.000825	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.18e-05	0.000822	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—SMO—glaucoma	5.16e-05	0.000818	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—OPN4—glaucoma	5.1e-05	0.000809	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	5.08e-05	0.000806	CbGpPWpGaD
Raloxifene—AOX1—Disease—CDKN2B—glaucoma	4.91e-05	0.000778	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP1B1—glaucoma	4.88e-05	0.000773	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ABCA1—glaucoma	4.88e-05	0.000773	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—CDKN2B—glaucoma	4.85e-05	0.00077	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HEYL—glaucoma	4.74e-05	0.000752	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RPTOR—glaucoma	4.73e-05	0.000749	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—SMO—glaucoma	4.71e-05	0.000746	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTGFR—glaucoma	4.59e-05	0.000728	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NCK2—glaucoma	4.58e-05	0.000726	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	4.46e-05	0.000707	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	4.39e-05	0.000696	CbGpPWpGaD
Raloxifene—EBP—Metabolism—NOS3—glaucoma	4.34e-05	0.000688	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RPTOR—glaucoma	4.32e-05	0.000684	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.31e-05	0.000683	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.3e-05	0.000682	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NR3C1—glaucoma	4.26e-05	0.000675	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.25e-05	0.000673	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NCK2—glaucoma	4.18e-05	0.000663	CbGpPWpGaD
Raloxifene—AOX1—Disease—MTHFR—glaucoma	4.12e-05	0.000652	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TXN—glaucoma	4.08e-05	0.000647	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CA1—glaucoma	4.07e-05	0.000645	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTGS2—glaucoma	3.97e-05	0.000629	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CTSA—glaucoma	3.94e-05	0.000625	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	3.93e-05	0.000623	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTM1—glaucoma	3.9e-05	0.000618	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HDAC9—glaucoma	3.89e-05	0.000617	CbGpPWpGaD
Raloxifene—AOX1—Disease—APOE—glaucoma	3.83e-05	0.000607	CbGpPWpGaD
Raloxifene—AOX1—Disease—CAV1—glaucoma	3.8e-05	0.000602	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CA5A—glaucoma	3.79e-05	0.0006	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NARFL—glaucoma	3.79e-05	0.0006	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—EDN1—glaucoma	3.74e-05	0.000594	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.73e-05	0.000591	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CA2—glaucoma	3.72e-05	0.00059	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.69e-05	0.000586	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.69e-05	0.000585	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RPTOR—glaucoma	3.59e-05	0.00057	CbGpPWpGaD
Raloxifene—AOX1—Disease—BAD—glaucoma	3.57e-05	0.000566	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HDAC9—glaucoma	3.55e-05	0.000563	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NCK2—glaucoma	3.48e-05	0.000552	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MTHFR—glaucoma	3.45e-05	0.000546	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CA1—glaucoma	3.44e-05	0.000546	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.44e-05	0.000546	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—EDN1—glaucoma	3.42e-05	0.000542	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EDN1—glaucoma	3.4e-05	0.000539	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.39e-05	0.000538	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CTSA—glaucoma	3.34e-05	0.000529	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—C3—glaucoma	3.27e-05	0.000519	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.26e-05	0.000516	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—APOE—glaucoma	3.21e-05	0.000509	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CAV1—glaucoma	3.18e-05	0.000504	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTT1—glaucoma	3.17e-05	0.000502	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CA2—glaucoma	3.15e-05	0.0005	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EDN1—glaucoma	3.1e-05	0.000492	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.08e-05	0.000488	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.08e-05	0.000488	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SMO—glaucoma	3.05e-05	0.000483	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—C3—glaucoma	2.99e-05	0.000473	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—C3—glaucoma	2.97e-05	0.000471	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HDAC9—glaucoma	2.96e-05	0.000469	CbGpPWpGaD
Raloxifene—AOX1—Disease—NOS3—glaucoma	2.87e-05	0.000455	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NTRK2—glaucoma	2.79e-05	0.000442	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SMO—glaucoma	2.78e-05	0.000441	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—C3—glaucoma	2.71e-05	0.00043	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTGS2—glaucoma	2.62e-05	0.000416	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TXN—glaucoma	2.62e-05	0.000416	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.55e-05	0.000405	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NTRK2—glaucoma	2.54e-05	0.000403	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP1B1—glaucoma	2.52e-05	0.0004	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ABCA1—glaucoma	2.52e-05	0.0004	CbGpPWpGaD
Raloxifene—AOX1—Disease—CDKN1B—glaucoma	2.49e-05	0.000394	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—CDKN2B—glaucoma	2.45e-05	0.000388	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—NOS3—glaucoma	2.4e-05	0.000381	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NGFR—glaucoma	2.39e-05	0.000379	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SMO—glaucoma	2.32e-05	0.000367	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NTRK1—glaucoma	2.27e-05	0.00036	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TXN—glaucoma	2.22e-05	0.000352	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTGS2—glaucoma	2.2e-05	0.000349	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NGFR—glaucoma	2.18e-05	0.000346	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NR3C1—glaucoma	2.15e-05	0.000341	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NTRK2—glaucoma	2.12e-05	0.000336	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CDKN2B—glaucoma	2.09e-05	0.000332	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NTRK1—glaucoma	2.07e-05	0.000329	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTT1—glaucoma	2.03e-05	0.000322	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.03e-05	0.000321	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTM1—glaucoma	2.02e-05	0.00032	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EDN1—glaucoma	2.01e-05	0.000318	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.01e-05	0.000318	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDKN2B—glaucoma	1.91e-05	0.000303	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CA1—glaucoma	1.85e-05	0.000293	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NGF—glaucoma	1.85e-05	0.000293	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EDN1—glaucoma	1.83e-05	0.000291	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NGFR—glaucoma	1.82e-05	0.000288	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CTSA—glaucoma	1.79e-05	0.000284	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MTHFR—glaucoma	1.78e-05	0.000283	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—C3—glaucoma	1.75e-05	0.000278	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NTRK1—glaucoma	1.73e-05	0.000274	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTT1—glaucoma	1.72e-05	0.000273	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CA2—glaucoma	1.69e-05	0.000268	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NGF—glaucoma	1.68e-05	0.000267	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—APOE—glaucoma	1.66e-05	0.000263	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CAV1—glaucoma	1.64e-05	0.000261	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APOE—glaucoma	1.63e-05	0.000259	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ABCA1—glaucoma	1.62e-05	0.000257	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP1B1—glaucoma	1.62e-05	0.000257	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CAV1—glaucoma	1.62e-05	0.000257	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—C3—glaucoma	1.6e-05	0.000254	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN2B—glaucoma	1.59e-05	0.000252	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FN1—glaucoma	1.54e-05	0.000244	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EDN1—glaucoma	1.53e-05	0.000242	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—BAD—glaucoma	1.52e-05	0.000241	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOE—glaucoma	1.49e-05	0.000236	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CAV1—glaucoma	1.48e-05	0.000234	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FN1—glaucoma	1.41e-05	0.000223	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NGF—glaucoma	1.4e-05	0.000222	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BAD—glaucoma	1.39e-05	0.00022	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.39e-05	0.00022	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ABCA1—glaucoma	1.37e-05	0.000217	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP1B1—glaucoma	1.37e-05	0.000217	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—C3—glaucoma	1.33e-05	0.000212	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTM1—glaucoma	1.3e-05	0.000205	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NOS3—glaucoma	1.24e-05	0.000197	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOE—glaucoma	1.24e-05	0.000197	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CAV1—glaucoma	1.23e-05	0.000195	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOS3—glaucoma	1.22e-05	0.000194	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TXN—glaucoma	1.19e-05	0.000189	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FN1—glaucoma	1.17e-05	0.000186	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BAD—glaucoma	1.16e-05	0.000183	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—glaucoma	1.14e-05	0.000181	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—glaucoma	1.14e-05	0.00018	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOS3—glaucoma	1.12e-05	0.000177	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTM1—glaucoma	1.1e-05	0.000174	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOE—glaucoma	1.07e-05	0.000169	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CDKN1B—glaucoma	1.06e-05	0.000168	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAV1—glaucoma	1.06e-05	0.000167	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—glaucoma	9.82e-06	0.000156	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—glaucoma	9.69e-06	0.000154	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDKN1B—glaucoma	9.68e-06	0.000153	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOS3—glaucoma	9.3e-06	0.000148	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTT1—glaucoma	9.24e-06	0.000146	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOE—glaucoma	9.02e-06	0.000143	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—glaucoma	8.96e-06	0.000142	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAV1—glaucoma	8.94e-06	0.000142	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—glaucoma	8.82e-06	0.00014	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN1B—glaucoma	8.06e-06	0.000128	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—glaucoma	8.05e-06	0.000128	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NOS3—glaucoma	7.98e-06	0.000127	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—glaucoma	7.47e-06	0.000118	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP1B1—glaucoma	7.36e-06	0.000117	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCA1—glaucoma	7.36e-06	0.000117	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—glaucoma	7.3e-06	0.000116	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NOS3—glaucoma	6.76e-06	0.000107	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—glaucoma	6.7e-06	0.000106	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—glaucoma	6.66e-06	0.000106	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—glaucoma	6.18e-06	9.8e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—glaucoma	6.08e-06	9.64e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTM1—glaucoma	5.88e-06	9.33e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—glaucoma	5.2e-06	8.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—glaucoma	5.07e-06	8.03e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOE—glaucoma	4.84e-06	7.68e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAV1—glaucoma	4.8e-06	7.61e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NOS3—glaucoma	3.63e-06	5.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—glaucoma	3.32e-06	5.26e-05	CbGpPWpGaD
